The IMPT serves as the ‘communications and information hub’ for the field of multipurpose prevention technologies (MPTs).
Our resource center features a searchable database, providing you access to global MPT research, technical webinars, trainee and career resources, advocacy tools, and more. Search our resources!
Resource Search
Search Results
MPTs & the IMPT Platform
MPTs & the IMPT Platform May 2021 The MPTs & the IMPT Platform is a PowerPoint presentation created by the IMPT Secretariat at CAMI Health to help our colleagues integrate MPTs into their talks and presentations. Please email IMPT@cami-health.org with any feedback on how you used this information. Download the presentation slide deck CAMI Health […]
The Power of MPTs: Combining Prevention of HIV, other STIs, and Pregnancy
The Power of MPTs: Combining Prevention of HIV, other STIs, and Pregnancy The IMPT’s Susanna Moore, Bethany Young Holt, and IMPT Advisory Council Member Thesla Palanee-Philips of Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, presented an introductory MPT panel at USAID’s Global Health Science and Practice Technical Exchange (GHTechX) in […]
Multipurpose Prevention Technologies: Strategy recommendations to guide the most promising products from the lab to hands of women
Multipurpose Prevention Technologies: Strategy recommendations to guide the most promising products from the lab to hands of women January, 2021 Recent results from long-acting HIV prevention trials in parallel with the MPTs in the pipeline herald an exciting time for the MPT field. However, given finite resources and technical challenges to advance products from preclinical […]
Critical actions to achieve the value potential of MPTs for prevention of HIV, other STIs, and unintended pregnancies among young women
23-27 July 2018 Amsterdam, the Netherlands Held at the 2018 International AIDS Conference, this interactive workshop involved a panel of influential interdisciplinary leaders and experts who discussed the current status of the MPT field and the priorities of funding organizations. It also included an energetic dialogue about ways to encourage the exploration of the funding […]
Technologies for comprehensive sexual and reproductive health prevention: The promise of MPTs
Technologies for comprehensive sexual and reproductive health prevention: The promise of MPTs 06-07 May 2018 San Francisco, CA, USA This session presentation enhanced the discussion on modernizing contraception by providing foundational knowledge about MPTs and the ever-growing pipeline database. It also engaged a new audience, especially youth in tech, in the movement to advance the […]
Prevention with a Twist: Developing MPTs with the End-User in Mind
Prevention with a Twist: Developing MPTs with the End-User in Mind 20-22 March 2018 Brussels, Belgium Briefly providing a background on MPTs, this presentation centered around the importance of incorporating end-user research at each stage of product development. Featuring lessons learned from the microbicide field and the product pipeline, it delivered key messages from the […]
Comprehensive Sexual & Reproductive Health Prevention: The Promise of MPTs
Comprehensive Sexual & Reproductive Health Prevention: The Promise of MPTs 17-18 January 2017 Oakland, CA, USA This presentation provided an overview of MPTs as innovative, breakthrough solutions that aim to deliver simultaneous prevention of at least two health risks: unintended pregnancy, HIV and other STIs. With an array of MPTs in development, it highlighted the […]
STIs and the Increasing Epidemiological Need for Innovative SRH Prevention: The Promise of MPTs
STIs and the Increasing Epidemiological Need for Innovative SRH Prevention: The Promise of MPTs 01-02 November 2016 Denver, CO, USA This presentation provided an overview of how the IMPT’s prioritization of actions to increase the awareness and development of MPTs can impact the incidence of unintended pregnancy, HIV and other STIs in the United States. […]
The Next Wave in HIV Prevention: Multipurpose Prevention Technologies (MPTs)
The Next Wave in HIV Prevention: Multipurpose Prevention Technologies (MPTs) 17 October 2016 Chicago, IL , USA Building from the key recommendations from the IMPT’s Clinical Evaluation Workshop and HC and MPTs Meeting for MPTs in September, the objective of this satellite was to further define the technical, clinical and market data required to justify […]
Putting hindsight to use: Applying lessons learned from family planning to new HIV prevention products and multipurpose prevention technologies
Putting hindsight to use: Applying lessons learned from family planning to new HIV prevention products and multipurpose prevention technologies 13 October 2016 Seattle, WA, USA The RHSC meeting organizers requested that the IMPT coordinate a joint panel with IPM to combine separate abstract submissions on new reproductive health technologies. The joint IMPT/IPM panel session objectives […]
Multipurpose Prevention Technologies (MPTs): a promising response to current challenges around hormonal contraceptive methods & HIV – Power Point
Multipurpose Prevention Technologies (MPTs): a promising response to current challenges around hormonal contraceptive methods & HIV – Power Point 27 January 2016 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Education MPTs Region(s): Global
New Developments in Barrier Contraception: Implications for Multipurpose Prevention Technologies (MPTs)
New Developments in Barrier Contraception: Implications for Multipurpose Prevention Technologies (MPTs) 14 November 2015 Panel session at the 2015 North American Forum on Family Planning in Chicago, IL This panel presented on the promising application of new contraceptive barrier methods in MPT development, and provided an outline of the MPT field as a whole. Presenters: […]
Multipurpose Prevention Technologies (MPTs): New reproductive health products on the horizon
Multipurpose Prevention Technologies (MPTs): New reproductive health products on the horizon 07 October 2015 Panel session during the New and Underused Reproductive Health Technologies (NURHT) Caucus at the 2015 Reproductive Health Supplies Coalition (RHSC) General Membership Meeting, in Oslo, Norway The session provided an overview of the MPT product development pipeline, and addressed key questions […]
Multipurpose Prevention Technologies (MPTs): Developing interventions to simultaneously prevent STIs, HIV and Pregnancy – Presentation
Multipurpose Prevention Technologies (MPTs): Developing interventions to simultaneously prevent STIs, HIV and Pregnancy – Presentation 16 September 2015 Panel session at the 2015 ISSTDR World STI & HIV Congress in Brisbane, Australia Co-sponsored by the World Health Organization (WHO), the University of California San Francisco (UCSF) Bixby Center, the Initiative for MPTs (IMPT), and the […]
Round Table Discussion: Multipurpose Prevention Technologies
Round Table Discussion: Multipurpose Prevention Technologies October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Risk Social/Behavioral Context
MPTs: What Are they, and Why Are they Needed?
MPTs: What Are they, and Why Are they Needed? October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Advocacy Product Development Risk
State of the Art: Multipurpose Prevention Technology Science and Product Development
State of the Art: Multipurpose Prevention Technology Science and Product Development October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development
Regulatory Considerations with Developing Combination Products
Regulatory Considerations with Developing Combination Products October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Product Type(s): MPTs Topic(s): Product Development Regulatory Issues
Study Designs for Evaluating the Effectiveness of Multipurpose Technologies
Study Designs for Evaluating the Effectiveness of Multipurpose Technologies October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Product Trials
Multipurpose Prevention Technologies
Multipurpose Prevention Technologies October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Epidemiology Social/Behavioral Context
Multipurpose Prevention Technologies: Impact Investing for Global Reproductive Health
Multipurpose Prevention Technologies: Impact Investing for Global Reproductive Health 05 September 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Collective Impact MPTs Product Development Risk
Women’s Health in Women’s Hands: The Promise of MPTs
Women’s Health in Women’s Hands: The Promise of MPTs 02 July 2014 The Stewart Center West at UCSF ANSIRH Oakland, CA CAMI hosted a panel and reception featuring Manjula Lusti-Narasimhan (WHO), Ina Park (CDPH/UCSF), Bethany Young Holt (CAMI/PHI) and others to discuss innovative prevention strategies that can simultaneously address risk for unintended pregnancies and STIs, […]
Supporting Agency Coordination and Cooperation in the Development of Contraceptive Methods Appropriate for Provision and Use in Low Resource Settings
Supporting Agency Coordination and Cooperation in the Development of Contraceptive Methods Appropriate for Provision and Use in Low Resource Settings November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Contraceptives Topic(s): Product Development
Introducing Novel Technologies at the Country Level; Promoting Approval, Access and Acceptance
Introducing Novel Technologies at the Country Level; Promoting Approval, Access and Acceptance November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Contraceptives Topic(s): Social/Behavioral Context SRH Linkages
The Development of Two Multipurpose Prevention Technology (MPT) Products, the Regulatory Pathway for Each, and the Initiation of Clinical Studies
The Development of Two Multipurpose Prevention Technology (MPT) Products, the Regulatory Pathway for Each, and the Initiation of Clinical Studies November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Product Trials Regulatory Issues
MPTs: Assessing Acceptability and Adherence
MPTs: Assessing Acceptability and Adherence November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Social/Behavioral Context
SILCS in South Africa: Opportunities for introduction as a barrier contraceptive and as an MPT
SILCS in South Africa: Opportunities for introduction as a barrier contraceptive and as an MPT November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Diaphragm MPTs Topic(s): Product Development Product Trials
Regional Priorities for Multipurpose Prevention Technologies: the Epidemiological and Demographic Data
Regional Priorities for Multipurpose Prevention Technologies: the Epidemiological and Demographic Data November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Epidemiology Product Development
The Reality on the Ground: What Users and Providers Want and Need in MPTs
The Reality on the Ground: What Users and Providers Want and Need in MPTs November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Social/Behavioral Context
Indian women’s perceptions of vaginal rings-feedback for development of multipurpose prevention technologies
Indian women’s perceptions of vaginal rings-feedback for development of multipurpose prevention technologies November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) MPTs Topic(s): Product Development Product Trials Social/Behavioral Context
Multipurpose Prevention Technologies (MPTs) for Sexual and Reproductive Health
Multipurpose Prevention Technologies (MPTs) for Sexual and Reproductive Health September 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Education Product Development
Multipurpose Prevention Technologies (MPTs) for Girls and Women
Multipurpose Prevention Technologies (MPTs) for Girls and Women 30 May 2013 Kuala Lumpur, Malaysia This panel session highlighted that MPTs would provide a greater selection for women to choose from based on their varying sexual and reproductive health (SRH) needs, and thus would empower women to control their own health. However, there are several challenges […]
Multipurpose Prevention Technologies (MPTs) for Girls and Women: Introduction
Multipurpose Prevention Technologies (MPTs) for Girls and Women: Introduction 30 May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Education Product Development
What are MPTs and why do we need them? What’s available now and on the horizon – Chandhiok
What are MPTs and why do we need them? What’s available now and on the horizon – Chandhiok 30 May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Education Product Development
Microbicides, where are we today?
Microbicides, where are we today? 30 May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Microbicides MPTs Topic(s): Product Development Product Trials
MPTs for sexual and reproductive health: meeting a critical need for women and their families
MPTs for sexual and reproductive health: meeting a critical need for women and their families 24 May 2013 Copenhagen, Denmark Session on MPTs at the European Society of Contraception and Reproductive Health (ESC): First Global Conference on Contraception, Reproductive and Sexual Health This session discussed the definition of MPTs, the global need among the female […]
MPTs available now and on the horizon
MPTs available now and on the horizon May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development
Aligning investments in MPT R&D and the critical path to MPT introduction
Aligning investments in MPT R&D and the critical path to MPT introduction May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development
Aligning investments in MPT Research & Development
Aligning investments in MPT Research & Development May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development
What do these technologies mean for women living with HIV?
What do these technologies mean for women living with HIV? May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Social/Behavioral Context
What are MPTs and why do we need them? What’s available now and on the horizon – Rees
What are MPTs and why do we need them? What’s available now and on the horizon – Rees May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Epidemiology Product Development
HIV Prevention and MPT Product Pipeline Update
HIV Prevention and MPT Product Pipeline Update 03 April 2013 click to view Presentation In this Presentation: Health Risk(s): HIV Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development
A Critical Look Down the Critical Path to MPT Development
A Critical Look Down the Critical Path to MPT Development 20-21 February 2013 Washington, DC, USA click to view Presentation In this Presentation: Health Risk(s): General SRH Product Type(s): MPTs Topic(s): Regulatory Issues Region(s): Global Working Group(s): Other
Identification of Key Attributes and Prioritization of Product Development
Identification of Key Attributes and Prioritization of Product Development December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development
Prioritising MPT Product – A Few Reflections
Prioritising MPT Product – A Few Reflections December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development